Tolerability of Repeat Use of Blue Light Cystoscopy with Hexaminolevulinate for Patients with Urothelial Cell Carcinoma

Journal of Urology

Volumn 197, Issue 3, 2017, Pages 596-601

  Lane, Giulia I ^a,b   Downs, Tracy M ^c   Soubra, Ayman ^a,b   Rao, Amrita ^d   Hemsley, Lauren ^b   Laylan, Christopher ^c   Shi, Fangfang ^c   Konety, Badrinath ^b  

^a VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

aminolevulinic acid; cystoscopy; drug related side effects and adverse reactions; photochemotherapy; urinary bladder neoplasms

Indexed keywords

AMINOLEVULINIC ACID HEXYL ESTER; ANTIHISTAMINIC AGENT; EYE DROPS; STEROID; 5-AMINOLEVULINIC ACID HEXYL ESTER; AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT;

ABSENCE OF COMPLICATIONS; ADULT; AGED; ALLERGIC REACTION; ARTICLE; BLADDER RUPTURE; BLUE LIGHT; BLUE LIGHT CYSTOSCOPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURGERY; CONTROLLED STUDY; CYSTOSCOPY; DRUG TOLERABILITY; EYE REDNESS; EYE SWELLING; FEMALE; GASTROINTESTINAL DISEASE; HEART DISEASE; HEMATURIA; HOSPITAL ADMISSION; HUMAN; LATEX ALLERGY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; REPEAT PROCEDURE; RETROSPECTIVE STUDY; STEROID THERAPY; TOPICAL TREATMENT; TRANSITIONAL CELL CARCINOMA; URINARY TRACT SURGERY; URINE RETENTION; UROGENITAL TRACT DISEASE; WHITE LIGHT CYSTOSCOPY; WHITE LIGHT ENDOSCOPY; ANALOGS AND DERIVATIVES; BLADDER TUMOR; CARCINOMA; MIDDLE AGED; PROCEDURES; UROTHELIUM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CARCINOMA; CYSTOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOSENSITIZING AGENTS; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 85010520685     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2016.09.076     Document Type: Article

References (13)

1. 1 Miller, K.D., Siegel, R.L., Lin, C.C., et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin, 66, 2016, 271.
2. 2 Wood DP: Tumors of the bladder. In: Campbell-Walsh Urology. Edited by AJ Wein, LR Kavoussi, AW Partin et al. Philadelphia: Elsevier 2016; p 2192.
3. 3 Grossman, H.B., Gomella, L., Fradet, Y., et al. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J Urol, 178, 2007, 62.
4. 4 Rink, M., Babjuk, M., Catto, J.W., et al. Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: a critical review of the current literature. Eur Urol, 64, 2013, 624.
5. 5 Chang, S.S., Boorjian, S.A., Chou, R., et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline. J Urol, 196, 2016, 1021.
6. 6 Photocure®: Cysview® (Hexaminolevulinate HCL) Prescribing Information 2011. Available at http://www.cysview.com/wp-content/uploads/2013/08/Prescribing-Information.pdf. Accessed July 8, 2016.
7. 7 Witjes, J.A., Gomella, L.G., Stenzl, A., et al. Safety of hexaminolevulinate for blue light cystoscopy in bladder cancer. A combined analysis of the trials used for registration and postmarketing data. Urology, 84, 2014, 122.
8. 8 U.S. Department of Health and Human Services, National Cancer Institute. Common Terminology Criteria for Adverse Events v. 4.0 (DHHS Publication No. 09-7473). 2009, U.S. Government Printing Office, Washington, DC.
9. 9 Burger, M., Grossman, H.B., Droller, M., et al. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. Eur Urol, 64, 2013, 846.
10. 10 Kausch, I., Sommerauer, M., Montorsi, F., et al. Photodynamic diagnosis in non-muscle-invasive bladder cancer: a systematic review and cumulative analysis of prospective studies. Eur Urol, 57, 2010, 595.
11. 11 Mitropoulos, D., Artibani, W., Graefen, M., et al. Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations. Eur Urol, 61, 2012, 341.
12. 12 Martin, R.C., Brennan, M.F., Jaques, D.P., Quality of complication reporting in the surgical literature. Ann Surg, 235, 2002, 803.
13. 13 Klem, B., Lappin, G., Nicholson, S., et al. Determination of the bioavailability of [14C]-hexaminolevulinate using accelerator mass spectrometry after intravesical administration to human volunteers. J Clin Pharmacol, 46, 2006, 456.